CBD Policy & Regulation Related News
Brexit will end medical cannabis access for sick children
Following the end of the UK’s Brexit transition period on 1 January 2021, British children with severe medical conditions will no longer be able...
EU court rules CBD is ‘not a narcotic’
In a landmark move the Court of Justice of the European Union (CJEU) has ruled the cannabinoid CBD is ‘not a narcotic’, as it...
FDA: cannabis, COVID-19 and misinformation
The US FDA’s Center for Drug Evaluation and Research tells us about the hazards of untested and unapproved cannabis treatments.
The US Center for Drug...
Discussing the need for evidence-based drug policy
Science for Democracy co-founder and former Italian Senator Marco Perduca tells MCN about the need for evidence-based drug policy.
International platform Science for Democracy (SfD)...
FDA given CBD regulation recommendations by NlHC
The National Industrial Hemp Council (NIHC) has recently given recommendations to the Food and Drug Administration (FDA) on CBD regulation.
The NIHC, which provides high-quality...
Professor Mike Barnes outlines opportunity in the UK’s CBD market
The UK's CBD market has flourished despite the impact of COVID-19.
The rest of the world has steamed ahead with the legalisation of medical and...
Opportunities in the CBD market with Always Pure Organics
With the recent announcement from the UK Government regarding its decision to enforce CBD's status as a Novel Food, it has consequently become more...
Currency UK: assessing the impact of COVID-19 on the CBD sector
Currency UK Head of Sales Ben Kohler assesses the impact of COVID-19 on foreign exchange within the CBD sector.
With CBD still being a relatively...
Medical cannabis research and policy in Israel
Yuval Landschaft, Director of the Israeli Medical Cannabis Agency, outlines Israel’s regulatory approach to cannabis-based medical treatment.
In recent years, there has been an increase...
Cannabis research, innovation, and policy in Australia
Professor Jennifer Martin, Chair of Clinical Pharmacology at the University of Newcastle and Director of the Australia Centre for Cannabinoid Clinical and Research Excellence,...
The Center for Medicinal Cannabis Research with Dr Igor Grant
In this article, Dr Igor Grant explores the work of the Center for Medicinal Cannabis Research.
When the Center for Medicinal Cannabis Research at UC...
‘A national disgrace’: call to improve medical cannabis access in the UK
A campaigner has urged the UK government to improve access to medical cannabis prescriptions as restrictive guidance from NICE and the BPNA has meant...
Cannabis law and policy in Gibraltar
Hassans International Law Firm Limited Partner Aaron Payas, CFA gives MCN an overview of Gibraltar’s cannabis landscape.
In October 2019, the government of Gibraltar approved...
CBD and Novel Foods regulation in the UK: regulation then and now
Always Pure Organics explores how CBD and Novel Foods regulation in the UK paves the way for a safer, more profitable industry, how best...
Medical Cannabis Network Quarterly Issue 3
Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our third edition, which looks at cannabis research, policy, and national and international regulation of cannabis.
Welcome...
White paper aims to accelerate cannabis integration into UK healthcare
A new white paper has been published by leaders in the cannabis field, showcasing how to maximise clinical research and improve patient access to...
Discover the EUMCA with Professor Trevor Jones
Professor Trevor Jones, Chairman of the European Medicinal Cannabis Association, tells MCN Digital Editor Stephanie Price about CBD quality standards, education and evidence-based policy.
Formed...
Novel Food Consortium to protect Europe’s hemp industry
The European Industrial Hemp Association has launched an industry consortium to share the burden of Novel Foods applications.
In the face of disparate and inconsistent...
Normal people: cannabis and policy in Norway
Ester Nafstad, Manager of Norwegian cannabis advocacy body Normal, tells MCN publication about the chapter’s goals and the need for reform of cannabis policy...
Policy, accessibility, and human rights in Malta
Andrew Bonello, President of Releaf Malta, speaks to MCN about policy, accessibility, human rights, and medical cannabis in Malta and the issues patients still...
